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OBJECTIVE — The rising incidence of type 1 diabetes has been attributed to environment,
implying a lesser role for genetic susceptibility. However, the rise could be accounted for by
either more cases with classic high-risk genes or by cases with other risk genes. Separately, for
any degree of genetic susceptibility, age at presentation may decrease in a permissive environ-
ment. To examine these possibilities, human leukocyte antigen (HLA) class II DRB1 genes
known to confer risk for type 1 diabetes were analyzed in relation to year of birth and age at
diagnosis over the last ﬁve decades.
RESEARCH DESIGN AND METHODS — Caucasoid subjects (n  462) diagnosed
with type 1 diabetes before age 18 between 1950 and 2005 were DRB1 genotyped.
RESULTS — Mean  SD age at diagnosis, 8.5  4.5 years, did not differ across decades.
Recentdiagnosiswasassociatedwithalowerproportionbutunchangedincidenceofthehighest-
risk DRB1 genotype DR3,4 (2000–2005, 28% vs. 1950–1969, 79%; P  0.0001) and a higher
proportion of lower-risk genotypes DR4,X and DR3,X (2000–2005, 48% vs. 1950–1969, 20%;
P0.0002).ThefrequencyoftheDRX,Xgenotypewaslow(3%)acrossdecades.Recentbirth
was associated with a lower age at diagnosis for lower risk DR3,3 and DR4,4 (P  0.0001) and
DR4,X (P  0.0001) and DR3,X (P  0.015) genotypes but not for DR3,4.
CONCLUSIONS — The rising incidence and decreasing age at diagnosis of type 1 diabetes
is accounted for by the impact of environment on children with lower-risk HLA class II genes,
who previously would not have developed type 1 diabetes in childhood.
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T
ype 1 diabetes is an autoimmune
disease that destroys the insulin-
producing -cells in the islets of the
pancreas, resulting in hyperglycemia and
associated complications. It is one of the
most common chronic diseases from
childhood, requiring continuous or mul-
tiple daily insulin injections and blood
glucose monitoring at substantial per-
sonal and economic cost. Genetic suscep-
tibility accounting for at least half the
lifetimerisk,togetherwithenvironmental
conditions, leads to the development of
type 1 diabetes (1). Although type 1 dia-
betes is a polygenic disease, the human
leukocyte antigen (HLA) genes, which
code for molecules that bind and present
peptide antigens to T-cells, account for
approximately half of the genetic risk
(2,3).
The incidence of childhood-onset
type 1 diabetes has been increasing pro-
gressively over the last half century (4,5).
Gillespie et al. (6) reported that the pro-
portion of children with the highest-risk
HLA genotype for type 1 diabetes (DR3,4
and DQ2,8) was signiﬁcantly lower in the
Bart’s-Oxford cohort of children in the
U.K. diagnosed between 1985 and 2002
compared with children in the Golden
Years cohort diagnosed between 1920
and1946.Ontheotherhand,thepropor-
tion of children with lower-risk geno-
types (DR4,X and DR3,X) was higher in
the Bart’s-Oxford cohort. Their ﬁndings
were consistent with a Finnish study by
Hermann et al. (7) in which children who
developed type 1 diabetes between 1939
and 1965 carried a higher proportion of
high-risk HLA genes compared with
thosediagnosedbetween1990and2001.
Gillespie et al. (6) concluded that “the ris-
ing incidence of type 1 diabetes in chil-
dren has resulted from exposure of a
genetically susceptible subgroup of the
population to an environment that is in-
creasinglyconducivetodiabetesdevelop-
ment.” Both Hermann et al. (7) and
Gillespie et al. (6) compared contempo-
rary subjects with cohorts diagnosed in
previous eras when survival from type 1
diabetes was signiﬁcantly less than it is
today. Their analyses were based on the
assumption that the HLA proﬁle of long-
term survivors was representative of that
of the whole population of children with
diabetes in the past, which is not neces-
sarily the case. In fact, Gillespie et al. (6)
acknowledge that only a minority of chil-
dren who developed diabetes in the
1940s and 1950s are likely to have sur-
vived to the present. Many studies have
documented improved survival rates, es-
pecially since the 1960s (8–10).
If the environment increasingly im-
pactsontheexpressionoftype1diabetes,
then the contribution of genetic suscepti-
bility in newly diagnosed cases may
change over time, and, for the same de-
gree of genetic susceptibility, age at diag-
nosis may decrease over time. We wanted
to test these possibilities while avoiding
selectionbiasinthereferencepopulation.
RESEARCH DESIGN AND
METHODS— Subjectswithtype1di-
abetes were from the Australian Type 1
Diabetes DNA Repository (11,12). They
had been diagnosed by a specialist physi-
cianonthebasisofhyperglycemiarequir-
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therapy. All subjects were of European
descent and lived in metropolitan Mel-
bourneorthewiderstateofVictoria.They
were recruited in an unselected manner
from diabetes clinics, including the Royal
Children’s Hospital, which until recently
followed up the majority of children and
teenagers with type 1 diabetes in Victoria.
Virtually all individuals with type 1 dia-
betes in Victoria attend diabetes clinics or
areseenbyspecialistswithattachmentsto
these clinics. Subjects (n  462) diag-
nosed before 18 years of age between
1950 and 2005 (91% after 1975) were
typed for HLA-DRB1 alleles.
HLA typing
HLA-DRB1genotypingwasperformedby
PCR-based sequence-speciﬁc oligonucle-
otide hybridization, modiﬁed from the
11th International Histocompatibility
Workshopprotocoltoaccommodatesub-
sequently described sequence polymor-
phisms (13). Brieﬂy, PCR primers were
designed to provide either generic or al-
lele-speciﬁcampliﬁcationofexon2ofthe
DRB1allele.ThePCR-ampliﬁedDNAwas
rendered single stranded by exposure to
sodium hydroxide, immobilized onto ny-
lon membranes, and hybridized with
biotinylated oligonucleotide probes de-
signedtodetectsequencepolymorphisms
between DRB1 alleles. Stringent washing
was performed in the presence of 3 mol/l
tetramethylammonium chloride and the
hybridized product detected using a
streptavidin/alkaline phosphatase conju-
gate and chemiluminescent substrate
CDP-star (Roche Diagnostics, Castle Hill,
NSW, Australia). Allele assignments were
made by comparing patterns of hybrid-
ization to those predicted from published
sequences.
Statistics
Subjects were grouped by decade of birth
or diagnosis (1950–1969, combined due
to small numbers; 1970–1979; 1980–
1989; 1990–1999; and 2000–2005) and
from the highest (DR3,4) to intermediate
(DR3,3orDR4,4;DR4,XorDR3,X)tothe
lowest (DRX,X, where X denotes a non-3
or non-4 allele) HLA genotypes for type 1
diabetes risk. Genotypes between decade
groups were compared by the 
2 test for
trend. Mean age at diagnosis across de-
cades was analyzed by ANOVA. Statistics
were performed with GraphPad Prism
version 3.0 software (La Jolla, CA).
RESULTS— The mean age at diagno-
sis of the total cohort of type 1 diabetes
subjects was (means  SD) 8.5  4.5
years, and this did not differ across de-
cades of diagnosis (P  0.54, ANOVA).
DRB1 genotypes were ﬁrst analyzed ac-
cording to decade of diagnosis. The pro-
portion of the highest-risk genotype,
DR3,4, decreased signiﬁcantly over time
from 79% in 1950–1969 to 28% in
2000–2005 (P  0.0001) (Table 1) (Fig.
1). On the other hand, the proportion of
the heterozygous intermediate-risk geno-
types, DR4,X and DR3,X, increased sig-
niﬁcantlyoverthisperiod(Table1);taken
together, they increased from 20 to 48%
(P  0.0002) (Fig. 1). Homozygosity for
DR4, but not DR3, increased over time,
andthelowest-riskgenotype,DRX,X,was
consistently low (3%) (Table 1).
Matched for DRB1 genotype and de-
cade of birth, subjects were analyzed for
age at diagnosis. There was no change
across time in age at diagnosis for the
high-risk DR3,4 genotype, but for the in-
termediateriskgenotypes(DR4,4;DR3,3;
DR4,X; and DR3,X) age at diagnosis de-
creased over time (Fig. 2).
The incidence of childhood-onset
type 1 diabetes in Australia has doubled
in the last 20 years, from 11.3 cases per
100,000 person-years in 1985 to 23.2 in
2002 (14). On the assumption that the
DRB1 genotype frequencies were repre-
sentative of the total population of indi-
viduals with type 1 diabetes, the
contributionofDRB1genotypestothein-
creasing incidence of type 1 diabetes was
examined. The numbers of incident cases
(rev. in 14) were related to speciﬁc DRB1
genotype proportions. As shown in Table
2, the population incidence of type 1 di-
abetes in subjects with the highest-risk
Figure 1—The proportion of HLA-DRB1 genotypes in childhood-onset type 1 diabetes according
to year of diagnosis (where X is a non-3 or non-4 DR allele).  , DR3,4; f, DR4,X and DR3,X.
Table 1— Proportion of HLA-DRB1 genotypes according to year of diagnosis of type 1 diabetes
HLA-DRB1
genotype
Year of diagnosis
P* 1950–1969 1970–1979 1980–1989 1990–1999 2000–2005
DR3,4 15 (79) 35 (60) 42 (47) 98 (37) 8 (28) 0.0001
DR4,4 0 (0) 5 (9) 4 (4) 31 (12) 4 (14) 0.039
DR3,3 0 (0) 7 (12) 7 (8) 19 (7) 2 (7) 0.800
DR4,X 2 (10) 8 (14) 28 (31) 68 (25) 10 (34) 0.034
DR3,X 2 (10) 1 (2) 7 (8) 42 (16) 4 (14) 0.009
DRX,X 0 (0) 2 (3) 1 (1) 9 (3) 1 (3) 0.950
Data are n (%). *P value is for trend across decades.
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changed. In contrast, the number of cases
with intermediate-risk genotypes (DR3,3
or DR4,4 and DR3,X or DR4,X) has in-
creased, accounting for the increase in
disease incidence.
CONCLUSIONS — HLA class II pro-
ﬁling demonstrates that the genetic con-
tribution in individuals diagnosed with
type 1 diabetes has changed over the last
ﬁve decades. The contemporary increase
in disease incidence is accounted for by
individuals with lower-risk HLA class II
genotypes who, in previous eras, would
not have developed diabetes in child-
hood. It would appear, therefore, that
changing environmental conditions have
increased the penetrance of these lower-
riskgenotypes.Ourﬁndingsaresimilarto
those reported in the northern hemi-
sphere (6,7) but are more likely to be free
ofselectionbiasbasedonsurvival,as91%
of our subjects were diagnosed after
1975. Subjects were unselected and pre-
dominantly of European Anglo-Celtic or-
igin, with no change over the decades to
suggest dilution by immigrants of other
ethnic backgrounds. Nevertheless, the
possibilitythattheywerenotentirelyrep-
resentative of the total population of indi-
viduals with type 1 diabetes across the
decades remains a potential limitation.
With this caveat, environmental condi-
tions operating in both hemispheres
therefore appear to be permissive for the
increasing incidence of type 1 diabetes
among individuals without the classic
high-risk DR3,4 genotype. Furthermore,
themeanageatdiagnosishasdecreasedin
children with lower-risk genotypes, rep-
resenting further evidence for the impact
of environment.
The temporal change in the genetic
contribution to type 1 diabetes raises sev-
eral points for discussion. First, studies of
type 1 diabetes may need to consider
stratiﬁcation by year of birth and diagno-
sis to dissect the relative inﬂuences of
genes and environment. This concept is
also more broadly relevant to other hu-
man diseases in which polygenetic sus-
ceptibility and environment interact.
Second, the HLA proﬁle of classic, child-
hood-onset type 1 diabetes has shifted
and is now similar to that of adults with
autoimmune diabetes, who are character-
ized as having lower-risk HLA genes
(15,16). However, adults diagnosed to-
daywithautoimmunediabeteswereborn
30 years ago when the contribution of
environment was presumably much less.
Born today, would they reach adulthood
before developing type 1 diabetes? Third,
it appears that the shift in the distribution
of HLA genotypes began in the 1980s. A
varietyofenvironmentalfactorsincluding
infectiousexposureinearlylife,thequan-
tity and composition of food intake, and
the amount of exercise and sleep (with
concomitant obesity) have been impli-
catedinpromotingtherisingincidenceof
type 1 diabetes. Since the 1980s, the in-
cidence of type 1 diabetes in Australia has
more then doubled (14). A change in in-
dividuals diagnosed in the 1980s could
reﬂect the impact of environmental fac-
tors acting in early life in the 1970s. Two
candidate factors may be worthy of com-
ment. First, up until the mid-1970s new-
borns in Victorian hospitals were housed
togetherinnurseriesforuptoaweek,but
this practice ceased when the high preva-
lenceofdiarrheaassociatedwithrotavirus
infection was found to be signiﬁcantly re-
duced by “rooming-in” with the mother
(17). The possibility that rotavirus infec-
tion in the neonate could protect against
type1diabetesissupportedbyﬁndingsin
the nonobese diabetic (NOD) mouse
model of the disease (18); interestingly,
though, rotavirus infection postweaning
in the NOD mouse did not protect but
rather increased disease incidence (18).
The latter result is consistent with our
Table 2—Incident cases of type 1 diabetes by HLA DRB1 genotype
1985 2002
Incidence 11.3/100,000
person-years*
Incidence 23.2/100,000
person-years
DRB1 genotype Proportion Cases† Proportion Cases
DR3,4 47% 5.3 28% 6.5
DR3,3 and DR4,4 12% 1.4 21% 4.9
DR3,X and DR4,X‡ 39% 4.4 48% 11.1
DRX,X 1% 0.1 3% 0.7
*Based on ref. 14. †Calculated as incidence times proportion DRB1 genotype.‡Where X is non-3 or non-4
DRB1 allele.
Figure 2—Mean age at diagnosis of type 1 diabetes by decade of birth according to HLA-DRB1
genotypes. Error bars indicate the standard deviation.
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nally in whom rotavirus infection was
positivelyassociatedwithevidenceofislet
autoimmunity (19). Second, the preva-
lence of obesity, and presumably insulin
resistance,inAustralianchildrenbeganto
accelerate in the 1970s (20). We have
shown that insulin resistance is an inde-
pendent risk factor for development of
type 1 diabetes in children with islet
autoimmunity(21).Therefore,insulinre-
sistance promoted by changing environ-
mental conditions may contribute to the
pathogenesis and rising incidence of type
1, as well as type 2, diabetes.
The stable incidence of DR3,4 across
time suggests that this genotype is resis-
tant to the inﬂuence of environment. One
interpretation is that adaptive T-cell–
mediatedimmunityresponsiblefor-cell
destructionisoptimalwithDR3,4butnot
with lower-risk genotypes. However, the
latter can be complemented by innate im-
munity promoted (together with insulin
resistance) by a proinﬂammatory envi-
ronment (22). Our ﬁndings illustrate that
the contribution of HLA genes to type 1
diabetes has changed but not lessened
over time. Indeed, genetic susceptibility
to type 1 diabetes is no less relevant as
moreindividualsfallundertheshadowof
a “diabetogenic” environment.
Acknowledgments— S.F. was a postgradu-
ate scholar supported by the Australian Na-
tional Health and Medical Research Council
(NHMRC). G.M. and L.C.H. are, respectively,
principalandseniorprincipalresearchfellows
of the NHMRC. Catherine McLean provided
valuable secretarial assistance.
References
1. Eisenbarth GS: Update in type 1 diabetes.
J Clin Endocrinol Metab 92:2403–2407,
2007
2. EisenbarthGS:Type1Diabetes:Molecular,
Cellular and Clinical Immunology. 2.5 ed.
Eisenbarth GS, Ed. Denver, CO, The Bar-
bara Davis Center for Childhood Diabe-
tes, 2007
3. Todd JA, Walker NM, Cooper JD, Smyth
DJ, Downes K, Plagnol V, Bailey R, Ne-
jentsev S, Field SF, Payne F, Lowe CE,
Szeszko JS, Haﬂer JP, Zeitels L, Yang JH,
Vella A, Nutland S, Stevens HE, Schuilen-
burg H, Coleman G, Maisuria M, Mead-
ows W, Smink LJ, Healy B, Burren OS,
Lam AA, Ovington NR, Allen J, Adlem E,
Leung HT, Wallace C, Howson JM, Guja
C, Ionescu-Tîrgoviste C, Genetics of Type
1 Diabetes in Finland, Simmonds MJ,
Heward JM, Gough SC, Dunger DB,
Wicker LS, Clayton DG, the Wellcome
Trust Case Control Consortium: Robust
associations of four new chromosome re-
gions from genome-wide analyses of type
1 diabetes. Nat Genet 39:857–864, 2007
4. Gale EA: The rise of childhood type 1 di-
abetes in the 20th century. Diabetes 51:
3353–3361, 2002
5. The DIAMOND Project Group: Incidence
and trends of childhood type 1 diabetes
worldwide 1990–1999. Diabet Med 23:
857–866, 2006
6. Gillespie KM, Bain SC, Barnett AH, Bing-
ley PJ, Christie MR, Gill GV, Gale EA: The
rising incidence of childhood type 1 dia-
betes and reduced contribution of high-
risk HLA haplotypes. Lancet 364:1699–
1700, 2004
7. Hermann R, Knip M, Veijola R, Simell O,
LaineAP,AkerblomHK,GroopPH,Fors-
blom C, Pettersson-Fernholm K, Ilonen J:
Temporal changes in the frequencies of
HLA genotypes in patients with type 1 di-
abetes: indication of an increased envi-
ronmental pressure? Diabetologia 46:
420–425, 2003
8. Marks HH: Longevity and mortality of di-
abetics. Am J Public Health 55:416–423,
1965
9. McNally PG, Raymond NT, Burden ML,
Burton PR, Botha JL, Swift PG, Burden
AC, Hearnshaw JR: Trends in mortality of
childhood-onset insulin-dependent dia-
betes mellitus in Leicestershire: 1940–
1991. Diabet Med 12:961–966, 1995
10. Nishimura R, LaPorte RE, Dorman JS, Ta-
jima N, Becker D, Orchard TJ: Mortality
trends in type 1 diabetes: the Allegheny
County (Pennsylvania) Registry 1965–
1999. Diabetes Care 24:823–827, 2001
11. Morahan G, Huang D, Ymer SI, Cancilla
MR,StephenK,DabadghaoP,WertherG,
Tait BD, Harrison LC, Colman PG: Link-
age disequilibrium of a type 1 diabetes
susceptibility locus with a regulatory
IL12B allele. Nat Genet 27:218–221,
2001
12. TaitBD,ColmanPG,MorahanG,Marchi-
novska L, Dore E, Gellert S, Honeyman
MC, Stephen K, Loth A: HLA genes asso-
ciated with autoimmunity and progres-
sion to disease in type 1 diabetes. Tissue
Antigens 61:146–153, 2003
13. Kimura A, Sasazuki T: Eleventh Interna-
tional Histocompatibility Workshop Refer-
ence Protocol for the HLA DNA-Typing
Technique. Oxford, Oxford University
Press, 1992
14. Haynes A, Bower C, Bulsara MK, Jones
TW, Davis EA: Continued increase in the
incidence of childhood type 1 diabetes in
a population-based Australian sample
(1985–2002). Diabetologia 47:866–870,
2004
15. Tuomi T, Carlsson A, Li H, Isomaa B, Mi-
ettinen A, Nilsson A, Nissen M, Ehrn-
strom BO, Forsen B, Snickars B, Lahti K,
Forsblom C, Saloranta C, Taskinen MR,
Groop LC: Clinical and genetic character-
istics of type 2 diabetes with and without
GAD antibodies. Diabetes 48:150–157,
1999
16. Fourlanos S, Dotta F, Greenbaum CJ,
Palmer JP, Rolandsson O, Colman PG,
Harrison LC: Latent autoimmune diabe-
tes in adults (LADA) should be less latent.
Diabetologia 48:2206–2212, 2005
17. Bishop RF, Cameron DJ, Veenstra AA,
Barnes GL: Diarrhoea and rotavirus infec-
tionassociatedwithdifferingregimensfor
postnatal care of newborn infants. J Clin
Microbiol 9:525–529, 1979
18. Harrison LC, Honeyman MC: Mucosa,
notmoocosa!InCommentariesonPerspec-
tives in Diabetes: 1988–1992. Vol. 3.
Robertson RP, Ed. American Diabetes As-
sociation, Alexandria, VA, 2006, p. 158
19. Honeyman MC Coulson BS, Stone NL,
Gellert SA, Goldwater PN, Steele CE,
Couper JJ, Tait BD, Colman PG, Harrison
LC: Association between rotavirus infec-
tion and pancreatic islet autoimmunity in
children at risk of developing type 1 dia-
betes. Diabetes 49:1319–1324, 2000
20. Norton K, Dollman J, Martin M, Harten
N:Descriptiveepidemiologyofchildhood
overweightandobesityinAustralia:1901–
2003. Int J Pediatr 1:232–238, 2006
21. Fourlanos S, Narendran P, Byrnes GB,
Colman PG, Harrison LC: Insulin resis-
tance is a risk factor for progression to
type 1 diabetes. Diabetologia 47:1661–
1667, 2004
22. Pickup JC: Inﬂammation and activated
innate immunity in the pathogenesis of
type 2 diabetes. Diabetes Care 27:813–
823, 2004
Fourlanos and Associates
DIABETES CARE, VOLUME 31, NUMBER 8, AUGUST 2008 1549